Welcome to the inaugural episode of The V3 Podcast, which launched Tuesday, July 2, 2019. The V3 podcast will showcase the vision, the voice and the value of Medical Affairs. Biopharma industry executive veteran, Dr. Anne Arvizu, will interview like-minded leaders and key global strategists who will share their knowledge, insights and new cutting-edge information. This higher-level look, at what keeps your patients first in our industry, will help you to position the role of medical affairs as the key driver for your organization and the Biopharma world moving forward. This is the Future of Medical Affairs.

The V3 Podcast is great for you if you: wishing you had a focused bit of time to learn more about medical affairs from a leadership perspective. V3 will give you the gift, first Tuesday of each month, to take about 30 minutes or more, to be equipped from the mindset at the executive levels. It’s also a great show for doctoral level leaders entering the industry, wanting to learn more and fast track their careers. As the show progresses, we’ll focus on various functions and hot topics within medical affairs that will be edifying and informational. You can expect to glean some actionable insights from every episode that you can immediately put into action. 

This first episode has been recorded as a solo anchor episode for our future guests. In this great standalone episode, Anne breaks down the threein V3; Vision. Voice and Value, as strategic elements pertaining to medical affairs. You’ll walk away understanding the impact that our practice has on the business that we support, and ultimately the patients we serve.

Please follow the show so you don’t miss an episode. And if you like what you hear, please tag and or follow @annearvizu and share on social media with the hashtag #V3Podcast and #medicalaffairs 

This show is being produced by the Pharmacy Podcast Network and is parter-sponsored by The Accreditation Council for Medical Affairs (ACMA) to help better serve the next generation of medical affairs leadership and adding value by supporting the medical experts and compliance leaders in our industry. You can find out more about ACMA here

About the Author

>